Search results
European Biosimilar Regulatory Update | JD Supra
JD Supra· 19 hours agoIn the past few weeks, the European Commission provided marketing authorization for biosimilars of denosumab and omalizumab, as well as an ophthalmic formulation of bevacizumab</ ...
S2 Episode 3: How Do You Treat Refractory Colorectal Cancer?
Medscape· 2 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
AbbVie's Immunogen Acquired Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated...
Benzinga· 9 hours agoThe study met its primary endpoint with an objective response rate (ORR) of 51.9%. The safety...
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 5 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC-9 mCRC Study, Etrumadenant ...
Newswise Expert | Shilpa Gupta, Case Western Reserve University
Newswise· 51 minutes agoDr. Gupt
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Zacks via Yahoo Finance· 3 days agoARC-9 is a phase Ib/II study evaluating the safety and efficacy of etrumadenant (E), a dual A2a/A2b...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 7 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Lymphadenectomy Not Needed in Advanced Ovarian Cancer With Optimal Surgery
MedPage Today· 4 days agoOmitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or...
Melatonin May Cut Risk for Age-Related Eye Disease
Medscape· 21 hours agoUse of the dietary supplement was seen to significantly reduce the risk for developing age-related macular degeneration and slow the progression of the...
Citi maintains buy on Arcus Biosciences stock By Investing.com
Investing.com· 3 days agoThe study showcased significant survival benefits for patients with third-line and beyond colorectal...
